clinical trial · NCT03540355
Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment
EMS·phase3·completed·n = 406
DyslipidemiasCipros 20 associationCrestor 20 mg
brief summary
The purpose of this study is to evaluate the efficacy of Cipros 20 association in the treatment of dyslipidemia treatment.
started
Mar 2, 2021
primary completion
Jan 23, 2025
completion
Jan 23, 2025
last updated
Jan 9, 2026
official title
Phase III, National, Multicenter, Randomized, Double-blind Clinical Trial, to Evaluate the Efficacy and Safety of Cipros 20 Association on the Dyslipidemia Treatment
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol